Cetera Advisor Networks’s Charles River Laboratories CRL Stock Holding History

Cetera Advisor Networks’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.51M	Buy	5,577 +44	+0.8%	+$10.5K	0.01%	1171
2023 Q4	$1.31M	Sell	5,533 -194	-3%	-$38.2K	0.01%	1208
2023 Q3	$1.12M	Sell	5,727 -265	-4%	-$54.4K	0.01%	1207
2023 Q2	$1.26M	Buy	5,992 +160	+3%	+$31.8K	0.01%	1109
2023 Q1	$1.18M	Sell	5,832 -85	-1%	-$19.3K	0.01%	1134
2022 Q4	$1.29M	Buy	+5,917	New	+$1.29M	0.01%	1039
2020 Q3	–	Sell	-248	Closed	-$43K	–	1563
2020 Q2	$43K	Buy	+248	New	+$39.6K	﹤0.01%	1985

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Cetera Advisor Networks's CRL Position: Q1 2024 in Review

Cetera Advisor Networks increased its Charles River Laboratories (CRL) stake by 0.8% in Q1 2024, buying an estimated $10.5K and bringing the position to 5,577 shares worth $1.51M. The position accounts for 0.01% of the portfolio, ranked #1171.

Cetera Advisor Networks first reported a position in CRL in Q2 2020 and has held it in 7 quarters since. 677 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

Cetera Advisor Networks held 5,577 shares of Charles River Laboratories worth $1.51M as of Q1 2024.
Cetera Advisor Networks bought 44 Charles River Laboratories shares in Q1 2024, an estimated $10.5K.
Charles River Laboratories made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1171 holding.
Cetera Advisor Networks first reported a position in Charles River Laboratories in Q2 2020 and has held it in 7 quarters since.
677 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.